POTENTIATION OF MYELOSUPPRESSION FROM CANCER-CHEMOTHERAPY AND THIAZIDE DIURETICS

被引：13

作者：

ORR, LE

机构：

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1981年 / 15卷 / 12期

关键词：

D O I：

10.1177/106002808101501209

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：967 / 970

页数：4

共 28 条

[1]

AMBRE JJ, 1971, J LAB CLIN MED, V78, P343

[2]

APPLE MA, 1975, DRUG THERAP, V5, P203

[3]

BAGLEY CM, 1973, CANCER RES, V33, P226

[4]

BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO

[5]

2-I

[6] CLINICAL PHARMACOLOGY OF ANTINEOPLASTIC AGENTS .2. [J].

CHABNER, BA ;

MYERS, CE ;

COLEMAN, N ;

JOHNS, DG .

[7] CLINICAL PHARMACOLOGY OF ANTINEOPLASTIC AGENTS .1. [J].

CHABNER, BA ;

MYERS, CE ;

COLEMAN, N ;

JOHNS, DG .

[8]

DIXON RL, 1968, P SOC EXP BIOL MED, V127, P1151

[9]

DIXON RL, 1965, FED PROC, V24, P454

[10]

FABER OK, 1974, N ENGL J MED, V29, P211